RPL13 and cancer: Some studies have shown that the upregulation of proteins involved in ribosome biogenesis mediates tumor development and treatment resistance in cancer models, such as the upregulation of gene expression of RPS13 (108), RPL13 (109), RPS15 (110), and RPS11 (111).